Hence, the objective of the present article is to establish a clinically relevant cut-off for ferritin levels to define iron deficiency, based on both plasma biomarkers (hepcidin and sTfR) as predictors of iron deficiency. This evidence concerns the gene HAMP and nutritional disorder.